UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055762
Receipt number R000063639
Scientific Title A Multicenter, Retrospective Study on the Risk of Non-Lung Cancer Death after Lobectomy and Sublobar Resection in Lung Cancer Patients
Date of disclosure of the study information 2024/10/07
Last modified on 2024/10/07 16:05:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Multicenter, Retrospective Study on the Risk of Non-Lung Cancer Death after Lobectomy and Sublobar Resection in Lung Cancer Patients

Acronym

Risk of Non-Lung Cancer Death and Surgical Procedure

Scientific Title

A Multicenter, Retrospective Study on the Risk of Non-Lung Cancer Death after Lobectomy and Sublobar Resection in Lung Cancer Patients

Scientific Title:Acronym

Risk of Non-Lung Cancer Death and Surgical Procedure

Region

Japan


Condition

Condition

Lung cancer

Classification by specialty

Chest surgery Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To determine whether there is an association between surgical procedure and the risk of death from other causes by retrospectively collecting data from multiple institutions on patients who have undergone curative resection for clinical stage I (7th edition) primary lung cancer and have not experienced recurrence of the primary disease.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Overall survival

Key secondary outcomes

Event-free survival by cause of death,overall survival by patient background factors


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients aged 18 years or older at the time of surgery who underwent complete resection for clinical stage IA or IB (TNM classification, 7th edition) primary lung cancer (or suspected) between January 1, 2013 and December 31, 2013.
2) Patients with a final pathological diagnosis of primary lung cancer (including small cell lung cancer).
3) Patients who have undergone lobectomy, segmentectomy (up to 4 segments, including subsegmentectomy), or partial resection.
4) Patients who have not been found to have a recurrence of the disease (or death from the disease).

Key exclusion criteria

1) Patients with a history of lung resection (including benign diseases).
2) Patients who have undergone preoperative treatment (drug therapy, radiation therapy, or chemoradiotherapy).
3) Patients who have undergone resection of more than one lobe (lobectomy + partial resection, lobectomy + segmentectomy, bi-lobectomy, pneumonectomy, etc.).
4) Patients who have undergone partial resection or segmentectomy of two or more separate parts of the lung.
5) Patients who have undergone bronchoplasty, vascularplasty, and combined resection of surrounding organs (chest wall, pericardium, etc.).
6) Patients who died within 30 days of surgery or died in hospital within 90 days of surgery.
7) Patients who refused to participate in the study.
8) Patients whom the investigator deems ineligible for any reason.

Target sample size

8000


Research contact person

Name of lead principal investigator

1st name Masayuki
Middle name
Last name Nakao

Organization

Cancer Institute Hospital, Japanese Foundation for Cancer Research

Division name

Department of Thoracic Surgical Oncology

Zip code

135-8550

Address

Cancer Institute Hospital, 3-8-31 Ariake, Koto-ku, Tokyo, Japan

TEL

0335200111

Email

masayuki.nakao@jfcr.or.jp


Public contact

Name of contact person

1st name Masyauki
Middle name
Last name Nakao

Organization

Cancer Institute Hospital, Japanese Foundation for Cancer Research

Division name

Department of Thoracic Surgical Oncology

Zip code

135-0062

Address

Cancer Institute Hospital, 3-8-31 Ariake, Koto-ku, Tokyo, Japan

TEL

0335200111

Homepage URL


Email

masayuki.nakao@jfcr.or.jp


Sponsor or person

Institute

Japanese Foundation for Cancer Research

Institute

Department

Personal name



Funding Source

Organization

The Japanese Association for Chest Surgery

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Cancer Institute Hospital, Japanese Foundation for Cancer Research

Address

3-8-31 Ariake, Koto-ku, Tokyo, Japan

Tel

0335200111

Email

med.shinsa@jfcr.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

がん研究会有明病院(東京都)


Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 05 Month 01 Day

Date of IRB

2024 Year 08 Month 22 Day

Anticipated trial start date

2024 Year 08 Month 22 Day

Last follow-up date

2026 Year 06 Month 30 Day

Date of closure to data entry

2026 Year 06 Month 30 Day

Date trial data considered complete


Date analysis concluded

2027 Year 12 Month 31 Day


Other

Other related information

A Multicenter, Retrospective Study


Management information

Registered date

2024 Year 10 Month 07 Day

Last modified on

2024 Year 10 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063639